BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25

• Press Releases

  The Emmes Group Appoints Dr. Rama Kondru as Chief Executive Officer

  August 24, 2026

   · 

  3 min read
• Press Releases

  Cycle Pharmaceuticals launches CAVHANZA™ (nilotinib) Orally Disintegrating Tablets (ODT), designed for use with PPIs and H₂RAs without food restrictions1

  August 24, 2026

   · 

  6 min read
• 

  FDA

  Capricor’s Duchenne therapy has new life after FDA grants 3-month extension

  The FDA has granted a three-month extension for Capricor Therapeutics’ Duchenne muscular dystrophy hopeful deramiocel in order to review additional data and consider a refined indication. The new target action date for the therapy is November 22.

  August 24, 2026

   · 

  2 min read

   · 

  Heather McKenzie
• Press Releases

  Seek Labs and NAMRU EURAFCENT Enter CRADA to Evaluate Field-Deployable Diagnostics for Infectious Diseases

  August 24, 2026

   · 

  2 min read
• Press Releases

  InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved

  August 24, 2026

   · 

  18 min read
• Press Releases

  Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)

  August 24, 2026

   · 

  3 min read
• Press Releases

  Zealand Pharma – Notification of holding of treasury shares

  August 24, 2026

   · 

  1 min read
• Press Releases

  Researchers Find No Connection Between Pesticide Exposure and Social Difficulties Common in Autism

  August 24, 2026

   · 

  7 min read
• Press Releases

  NorthPalm Commits Entire Cybeats Position to a 12-Month Lock-Up; 60 Million Shares Representing Approximately 30% of Cybeats

  August 24, 2026

   · 

  3 min read
• Press Releases

  IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2026

  August 24, 2026

   · 

  1 min read